WO2023234899 - A BILAYER TABLET FORMULATION COMPRISING EMPAGLIFLOZIN AND METFORMIN
National phase entry:
Publication Number
WO/2023/234899
Publication Date
07.12.2023
International Application No.
PCT/TR2023/050469
International Filing Date
25.05.2023
Title **
[English]
A BILAYER TABLET FORMULATION COMPRISING EMPAGLIFLOZIN AND METFORMIN
[French]
FORMULATION DE COMPRIMÉ BICOUCHE COMPRENANT DE L'EMPAGLIFLOZINE ET DE LA METFORMINE
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
SUNEL, Fatih
PEHLIVAN AKALIN, Nur
ARMUT, Merve
GULER, Tolga
Priority Data
2022/008870
31.05.2022
TR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2075 | |
| EPO | Filing, Examination, Granting | 9345 | |
| Japan | Filing, Examination, Granting | 2166 | |
| South Korea | Filing, Examination, Granting | 2034 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,360
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a bilayer tablet comprising empagliflozin and metformin, the tablet provides the desired stability and pharmacotechnical properties and the desired dissolution profile. The present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient method of preparing the bilayer tablet.[French]
La présente invention concerne un comprimé bicouche comprenant de l'empagliflozine et de la metformine, le comprimé assurant la stabilité et les propriétés pharmacotechniques souhaitées et le profil de dissolution souhaité. La présente invention concerne également un procédé simple, rapide, économique, économe en temps et industriellement pratique de préparation du comprimé bicouche.